NCT03448627

Brief Summary

Pulmonary functions, exercise capacity and muscle strength deteriorate in survived hematopoietic stem cell transplantation (HSCT) recipients due to toxic effects of chemotherapy, radiotherapy, conditioning regimens and/or corticosteroid use before HSCT, prolonged stay of recipients in rooms with laminar airflow and strict infection control rules during process of HSCT. There are also limited numbers of studies demonstrated pulmonary function abnormalities, decreased maximal exercise capacity, respiratory and peripheral muscle weakness in recipients. Current study was planned since no study compared pulmonary functions, maximal exercise capacity, respiratory and peripheral muscle strength between recipients and healthy individuals in the literature.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
122

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2012

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2012

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2014

Completed
3.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

February 22, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 28, 2018

Completed
Last Updated

April 16, 2019

Status Verified

April 1, 2019

Enrollment Period

2.7 years

First QC Date

February 22, 2018

Last Update Submit

April 11, 2019

Conditions

Keywords

stem cell transplantationPulmonary Functionsmuscle strengthexercise capacity

Outcome Measures

Primary Outcomes (1)

  • Modified-Incremental Shuttle Walk Test (ISWT)

    This test was used to evaluate maximal exercise capacity

    15-20 minutes

Secondary Outcomes (3)

  • pulmonary function test

    5 minutes

  • inspiratory and expiratory muscle strength (MIP, MEP)

    5-10 minutes

  • Quadriceps femoris muscle strength

    5 minutes

Study Arms (2)

Group 1: HSCT recipients

Pulmonary functions \[spirometry\], maximal exercise capacity \[Modified-Incremental Shuttle Walk Test (ISWT)\], inspiratory and expiratory muscle strength (MIP and MEP, respectively) \[mouth pressure device\] and peripheral muscle strength \[hand-held dynamometer\] were evaluated in allogeneic HSCT recipients (n=66).Vital signs, dyspnea and fatigue perception \[Modified Borg Scale\] were recorded as pre-post measurements of Modified-ISWT.

Group 2: healthy individuals

Healthy individuals (n=50) were selected from individuals without known and diagnosed any chronic diseases. Similar measurements were applicated in healthy individuals.

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

66 recipients underwent allogeneic HSCT who were at minimum 100 days status post-transplantation compared with 50 healthy individuals. All recipients transplanted at the Bone Marrow Transplantation Unit of University Faculty of Medicine. All measurements were done by a physiotherapist at Cardiopulmonary Unit of University Faculty of Health Science Department of Physiotherapy and Rehabilitation. Demographic and clinical characteristics of all participants were recorded. Study was planned as retrospective, cross sectional and approved by the local Ethics Committee. Informed consent was obtained from all individual participants included in the study.

You may qualify if:

  • between ages of 18 and 70
  • under standard medical treatment
  • underwent allogeneic HSCT who were at minimum 100 days status post-transplantation

You may not qualify if:

  • having cognitive disorder, orthopedic or neurological disease with a potential to affect assessment of maximal exercise capacity,
  • having comorbidities such as asthma, chronic obstructive pulmonary disease (COPD), acute respiratory or other infections,
  • having problems like visual and mucositis which may prevent measurements,
  • acute hemorrhage anywhere in the body,
  • hemoglobin value less than 8 g/L and platelet count less than 10.000 mm3
  • being individuals without known and diagnosed any chronic diseases
  • not actively smoking
  • their cigarette exposure is not greater than 5 pack\*year.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gazi University Faculty of Health Science Department of PhysioTherapy

Ankara, 06010, Turkey (Türkiye)

Location

Related Publications (7)

  • Kovalszki A, Schumaker GL, Klein A, Terrin N, White AC. Reduced respiratory and skeletal muscle strength in survivors of sibling or unrelated donor hematopoietic stem cell transplantation. Bone Marrow Transplant. 2008 Jun;41(11):965-9. doi: 10.1038/bmt.2008.15. Epub 2008 Feb 11.

  • Morishita S, Kaida K, Yamauchi S, Sota K, Ishii S, Ikegame K, Kodama N, Ogawa H, Domen K. Relationship between corticosteroid dose and declines in physical function among allogeneic hematopoietic stem cell transplantation patients. Support Care Cancer. 2013 Aug;21(8):2161-9. doi: 10.1007/s00520-013-1778-7. Epub 2013 Mar 9.

  • Knols RH, de Bruin ED, Uebelhart D, Aufdemkampe G, Schanz U, Stenner-Liewen F, Hitz F, Taverna C, Aaronson NK. Effects of an outpatient physical exercise program on hematopoietic stem-cell transplantation recipients: a randomized clinical trial. Bone Marrow Transplant. 2011 Sep;46(9):1245-55. doi: 10.1038/bmt.2010.288. Epub 2010 Dec 6.

  • Shelton ML, Lee JQ, Morris GS, Massey PR, Kendall DG, Munsell MF, Anderson KO, Simmonds MJ, Giralt SA. A randomized control trial of a supervised versus a self-directed exercise program for allogeneic stem cell transplant patients. Psychooncology. 2009 Apr;18(4):353-9. doi: 10.1002/pon.1505.

  • Morishita S, Kaida K, Yamauchi S, Wakasugi T, Ikegame K, Ogawa H, Domen K. Relationship of physical activity with physical function and health-related quality of life in patients having undergone allogeneic haematopoietic stem-cell transplantation. Eur J Cancer Care (Engl). 2017 Jul;26(4). doi: 10.1111/ecc.12669. Epub 2017 Feb 21.

  • Bargi G, Guclu MB, Aribas Z, Aki SZ, Sucak GT. Inspiratory muscle training in allogeneic hematopoietic stem cell transplantation recipients: a randomized controlled trial. Support Care Cancer. 2016 Feb;24(2):647-659. doi: 10.1007/s00520-015-2825-3. Epub 2015 Jul 2.

  • Bird L, Arthur A, Niblock T, Stone R, Watson L, Cox K. Rehabilitation programme after stem cell transplantation: randomized controlled trial. J Adv Nurs. 2010 Mar;66(3):607-15. doi: 10.1111/j.1365-2648.2009.05232.x.

Study Officials

  • Gülşah Barğı, PhD

    Gazi University

    STUDY CHAIR
  • Meral Boşnak Güçlü, PhD

    Gazi University

    STUDY DIRECTOR
  • Gülsan Türköz Sucak

    Bahçeşehir University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

February 22, 2018

First Posted

February 28, 2018

Study Start

March 1, 2012

Primary Completion

November 1, 2014

Study Completion

December 1, 2017

Last Updated

April 16, 2019

Record last verified: 2019-04

Data Sharing

IPD Sharing
Will not share

There is not a plan to make individual participant data but when the statistical analyses of all data are made, all results will be shared.

Locations